Nothing Special   »   [go: up one dir, main page]

PT1765288E - Métodos de tratamento de infeções endobrônquicas - Google Patents

Métodos de tratamento de infeções endobrônquicas Download PDF

Info

Publication number
PT1765288E
PT1765288E PT57660649T PT05766064T PT1765288E PT 1765288 E PT1765288 E PT 1765288E PT 57660649 T PT57660649 T PT 57660649T PT 05766064 T PT05766064 T PT 05766064T PT 1765288 E PT1765288 E PT 1765288E
Authority
PT
Portugal
Prior art keywords
formualtions
tobramycin
treatment
endobronchial infections
endobronchial
Prior art date
Application number
PT57660649T
Other languages
English (en)
Inventor
Peter Challoner
Carlos Rodriguez
John D Lord
Emil Samara
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1765288E publication Critical patent/PT1765288E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT57660649T 2004-06-18 2005-06-20 Métodos de tratamento de infeções endobrônquicas PT1765288E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18

Publications (1)

Publication Number Publication Date
PT1765288E true PT1765288E (pt) 2013-01-29

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
PT57660649T PT1765288E (pt) 2004-06-18 2005-06-20 Métodos de tratamento de infeções endobrônquicas

Country Status (25)

Country Link
US (3) US20080214481A1 (pt)
EP (1) EP1765288B1 (pt)
JP (3) JP2008503500A (pt)
KR (2) KR20070026604A (pt)
CN (1) CN101014320B (pt)
AU (1) AU2005258078B2 (pt)
BR (1) BRPI0512146A (pt)
CA (1) CA2570976C (pt)
DK (1) DK1765288T3 (pt)
EC (1) ECSP077182A (pt)
ES (1) ES2399279T3 (pt)
HR (1) HRP20130076T1 (pt)
IL (1) IL179873A (pt)
MA (1) MA28740B1 (pt)
MX (1) MXPA06014567A (pt)
NO (1) NO338799B1 (pt)
NZ (1) NZ552047A (pt)
PL (1) PL1765288T3 (pt)
PT (1) PT1765288E (pt)
RU (1) RU2389477C2 (pt)
SG (1) SG153833A1 (pt)
SI (1) SI1765288T1 (pt)
TN (1) TNSN06420A1 (pt)
WO (1) WO2006002178A1 (pt)
ZA (1) ZA200700420B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1458360B1 (en) * 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
EP2083833B1 (en) * 2006-10-11 2018-01-24 Laboratoires SMB SA Pharmaceutical anti-infective composition for inhalation.
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
US8834930B2 (en) 2008-05-15 2014-09-16 Novartis Ag Pulmonary delivery of a fluoroquinolone
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
KR101748892B1 (ko) 2009-05-29 2017-06-19 펄 테라퓨틱스 인코포레이티드 지속형 무스카린 안타고니스트 및 지속형 ｂ₂아드레날린 수용체 아고니스트의 폐 전달용 조성물, 및 연관된 방법 및 시스템
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP3923295A1 (en) 2009-08-31 2021-12-15 Abbott Diabetes Care, Inc. Medical devices and methods
UA107095C2 (uk) * 2009-12-14 2014-11-25 Антибіотичні мікрочастинки для інгаляції
ES2924054T3 (es) 2010-03-24 2022-10-04 Abbott Diabetes Care Inc Insertadores de dispositivos médicos
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
EP2731586B1 (en) 2011-07-12 2019-09-25 Savara Inc. Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
EP2713879B1 (en) 2011-12-11 2017-07-26 Abbott Diabetes Care, Inc. Analyte sensor devices, connections, and methods
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
TR201902687T4 (tr) 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
AU2016260547B2 (en) 2015-05-14 2020-09-03 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
WO2018136898A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2224175B1 (pt) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
AU662919B2 (en) 1991-07-02 1995-09-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
CA2190502A1 (en) 1994-05-18 1995-11-23 Robert M. Platz Methods and compositions for the dry powder formulation of interferons
PL187750B1 (pl) 1994-09-21 2004-09-30 Nektar Therapeutics Sposób i urządzenie do wytwarzania aerozolu ze sproszkowanego leku
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
CN1348377A (zh) * 1998-12-17 2002-05-08 希龙公司 用气溶胶化的抗生素治疗严重慢性支气管炎(支气管扩张症)的方法
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
WO2001013891A2 (en) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
PT1320355E (pt) 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
WO2003041777A1 (en) 2001-11-14 2003-05-22 Nektar Therapeutics Aerosolization device with improved endpiece connection
AU2002340481B2 (en) 2001-11-14 2008-07-17 Novartis Ag Aerosolization apparatus comprising connectable body and endpiece
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
WO2003057593A1 (en) 2001-12-21 2003-07-17 Nektar Therapeutics Capsule package with moisture barrier
JP2005530765A (ja) 2002-05-07 2005-10-13 ネクター セラピューティクス 乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Also Published As

Publication number Publication date
JP2012107047A (ja) 2012-06-07
DK1765288T3 (da) 2013-02-11
JP2008503500A (ja) 2008-02-07
RU2007101906A (ru) 2008-07-27
KR20120131245A (ko) 2012-12-04
IL179873A (en) 2014-09-30
AU2005258078A1 (en) 2006-01-05
US20110097412A1 (en) 2011-04-28
ZA200700420B (en) 2008-05-28
MA28740B1 (fr) 2007-07-02
BRPI0512146A (pt) 2008-02-12
SG153833A1 (en) 2009-07-29
EP1765288A1 (en) 2007-03-28
JP2013056947A (ja) 2013-03-28
WO2006002178A1 (en) 2006-01-05
EP1765288B1 (en) 2012-11-07
CA2570976A1 (en) 2006-01-05
RU2389477C2 (ru) 2010-05-20
PL1765288T3 (pl) 2013-04-30
KR20070026604A (ko) 2007-03-08
EP1765288A4 (en) 2009-05-13
US8664187B2 (en) 2014-03-04
HRP20130076T1 (hr) 2013-03-31
US20120148641A1 (en) 2012-06-14
NO20070253L (no) 2007-03-13
SI1765288T1 (sl) 2013-02-28
ES2399279T3 (es) 2013-03-27
CN101014320A (zh) 2007-08-08
CA2570976C (en) 2013-08-13
CN101014320B (zh) 2011-05-18
TNSN06420A1 (en) 2008-02-22
US20080214481A1 (en) 2008-09-04
AU2005258078B2 (en) 2010-09-30
ECSP077182A (es) 2007-05-30
MXPA06014567A (es) 2007-07-24
IL179873A0 (en) 2007-05-15
NZ552047A (en) 2009-11-27
NO338799B1 (no) 2016-10-24

Similar Documents

Publication Publication Date Title
SI1765288T1 (sl) Formulacije tobramicina za zdravljenje endobronhialnih infekcij
IL257622B (en) Methods and preparations for the treatment of persistent infections
PL1951272T3 (pl) Zastosowanie lactobacillus do leczenia infekcji wirusowych
HK1221956A1 (zh) 用於治療感染的鹵代類苯酞化硼
EP1871331A4 (en) COMPOSITION FOR THE TREATMENT OF MENOPAUSE
HK1134679A1 (zh) 用於治療感染的組合物和方法
IL178207A0 (en) Dalbavancin compositions for treatment of bacterial infections
ZA200709727B (en) Compounds and methods for the treatment of prevention of flavivirus infections
ZA200704392B (en) Antibiotic combinations for providing total solution to the treatment of infections
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
EP1881760A4 (en) ANTIMICROBIAL TREATMENT FOR BACTERIAL INFECTIONS
LT2111855T (lt) Antibakteriės kompozicijos, skirtos viršutinių ir apatinių kvėpavimo takų infekcijų gydymui
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
IL180459A0 (en) Treatment of bacterial infections
GB0513096D0 (en) Treatment of microbial infections
ZA200704775B (en) Compositions for treatment of ear infections
HU0500947D0 (en) Composition for treatment of paradontosis
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
PL376876A1 (pl) Środki farmaceutyczne do pomocniczego leczenia chorób infekcyjnych u ptaków
GB0622841D0 (en) Treatment of staphylococcal infections